Article info
PDFCorrespondence
Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia
- Correspondence to Associate Professor Rachael L Morton, NHMRC Clinical Trials Centre, Camperdown, NSW 2050, Australia; rachael.morton{at}ctc.usyd.edu.au
Citation
Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia
Publication history
- Received December 6, 2018
- Accepted December 9, 2018
- First published January 3, 2019.
Online issue publication
February 19, 2019
Article Versions
- Previous version (19 February 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.